Abstract

Clustered regularly interspaced short palindromic repeat (CRISPR) RNA-guided nucleases have gathered considerable excitement as a tool for genome engineering. However, questions remain about the specificity of target site recognition. Cleavage specificity is typically evaluated by low throughput assays (T7 endonuclease I assay, target amplification followed by high-throughput sequencing), which are limited to a subset of potential off-target sites. Here, we used ChIP-seq to examine genome-wide CRISPR binding specificity at gRNA-specific and gRNA-independent sites for two guide RNAs. RNA-guided Cas9 binding was highly specific to the target site while off-target binding occurred at much lower intensities. Cas9-bound regions were highly enriched in NGG sites, a sequence required for target site recognition by Streptococcus pyogenes Cas9. To determine the relationship between Cas9 binding and endonuclease activity, we applied targeted sequence capture, which allowed us to survey 1200 genomic loci simultaneously including potential off-target sites identified by ChIP-seq and by computational prediction. A high frequency of indels was observed at both target sites and one off-target site, while no cleavage activity could be detected at other ChIP-bound regions. Our results confirm the high-specificity of CRISPR endonucleases and demonstrate that sequence capture can be used as a high-throughput genome-wide approach to identify off-target activity.

Highlights

  • Targeted genome engineering by nucleases has enabled researchers to alter genetic content in a variety of cell types and organisms

  • We demonstrate that sequence capture can be used as an efficient approach to interrogate Cas9 nuclease off-target activity at a large number of genomic regions simultaneously

  • In the case of the Cas9:gRNA:DNA complex, we are interested in protein– DNA interactions that are facilitated by the guide RNA

Read more

Summary

Introduction

Targeted genome engineering by nucleases has enabled researchers to alter genetic content in a variety of cell types and organisms. Wild-type Cas nuclease acts by introducing double strand breaks at the DNA target site that are either repaired by NHEJ (non homologous end joining) or HR (homologous recombination). Single amino acid mutations in the nuclease domains convert Cas nuclease into a nickase, while introducing two amino acid changes (D10A and H840A) result in a nuclease-inactive DNA binding protein (dCas9) [4]. DCas could be fused to domains that regulate the epigenetic landscape at endogenous loci. This strategy has shown potential for zinc finger and transcription activator-like effector (TALE) DNA binding proteins [10,11,12,13]. The versatility and ease of use make CRISPR/Cas a powerful tool for genome editing and gene regulation, but our understanding of binding specificity and target recognition remains limited

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call